Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Endocrine Oncology (Bristol, England)|September 2, 2025
Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomasEleni Armeni, Alexander Branton, Juliana Porto, et al.Journal of Neuroendocrinology|November 6, 2024
Neuroendocrine tumours and pregnancy: Real-world data from an European Neuroendocrine Tumour Centre of ExcellenceGowri M Ratnayake, Kalyan Mansukhbhai Shekhda, Thomas Glover, et al.Pancreas|May 3, 2021
High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective AnalysisAimee R Hayes, Myles Furnace, Ruchir Shah, et al.Cancers|July 27, 2024
The Clinical Utility of the NETest in Patients with Small Intestinal Neuroendocrine Neoplasms (Si-NENs): A "Real-Life" StudyJulian Gertner, Marina Tsoli, Aimee R Hayes, et al.Neuroendocrinology|June 17, 2020
Antiproliferative Effect of Above-Label Doses of Somatostatin Analogs for the Management of Gastroenteropancreatic Neuroendocrine TumorsLeonidas Nikolaos Diamantopoulos, Faidon-Marios Laskaratos, Markos Kalligeros, et al.Endocrine Oncology (Bristol, England)|September 22, 2025
68Ga-DOTA-TATE PET/CT improves accuracy and guides management in multiple endocrine neoplasia type 1 (MEN-1) patients with suspected duodeno-pancreatic neuroendocrine tumoursKalyan Vamshi Vemulapalli, Kalyan Mansukhbhai Shekhda, Gowri Ratnayake, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United KingdomEvangelia Skoura, Sofia Michopoulou, Mullan Mohmaduvesh, et al.Endocrine|June 13, 2021
Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?Klaire Exarchou, Lukasz Kamieniarz, Marina Tsoli, et al.Endocrine Oncology (Bristol, England)|October 27, 2025
177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of ExcellenceKalyan Mansukhbhai Shekhda, Eleni Armeni, Yiwang Xu, et al.Endocrine-Related Cancer|April 20, 2026
Unravelling Mesenteric Fibrosis in Small Intestinal Neuroendocrine Tumours and Implications for Clinical ManagementMaria Castanho Martins, Eva van der Slik, Johannes Hofland, et al.Pageof 12